Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study

Introduction : On average, 19–23% of patients with acute myocardial infarction (MI) suffer from type 2 diabetes mellitus, which is newly diagnosed in a significant number of patients. Both classic carbohydrate metabolism and lipid metabolism may be promising diagnostic markers for insulin resistance...

Full description

Bibliographic Details
Main Authors: Olga Barbarash, Olga Gruzdeva, Evgenya Uchasova, Ekaterina Belik, Yulia Dyleva, Victoria Karetnikova
Format: Article
Language:English
Published: Termedia Publishing House 2017-01-01
Series:Archives of Medical Science
Subjects:
Online Access:https://www.termedia.pl/Biochemical-markers-of-type-2-diabetes-as-a-late-complication-of-myocardial-infarction-a-case-control-study,19,29146,1,1.html
id doaj-712783830055424bb6da741c8065595d
record_format Article
spelling doaj-712783830055424bb6da741c8065595d2020-11-25T00:33:02ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512017-01-0113231132010.5114/aoms.2017.6524029146Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control studyOlga BarbarashOlga GruzdevaEvgenya UchasovaEkaterina BelikYulia DylevaVictoria KaretnikovaIntroduction : On average, 19–23% of patients with acute myocardial infarction (MI) suffer from type 2 diabetes mellitus, which is newly diagnosed in a significant number of patients. Both classic carbohydrate metabolism and lipid metabolism may be promising diagnostic markers for insulin resistance in acute coronary syndrome. Material and methods : Two hundred patients (130 males and 70 females aged 61.4 ±1.12 years) with ST-segment elevation MI were included in the study. Patients were divided into two groups based on manifestations of diabetes: (1) 171 patients without diabetes within 1 year after MI; and (2) 29 patients with manifestations of diabetes. The control group comprised 33 people without diseases of the cardiovascular system and diabetes and was matched by age and gender with patients. Results : In patients with an imbalanced adipokine state during the acute phase of MI, we noted an increased concentration of free fatty acids (p > 0.05) and reduced ghrelin levels and activation of the proinflammatory and thrombotic potentials of blood plasma. Patients who developed diabetes 1 year after MI showed hospital stays with more pronounced changes in the study parameters. Conclusions : The most informative biochemical parameters associated with the development of diabetes at 1 year after MI were adiponectin, retinol protein, ghrelin, tumor necrosis factor , and plasminogen activator inhibitor.https://www.termedia.pl/Biochemical-markers-of-type-2-diabetes-as-a-late-complication-of-myocardial-infarction-a-case-control-study,19,29146,1,1.htmltype 2 diabetes mellitus adipokines ghrelin tumor necrosis factor  myocardial infarction
collection DOAJ
language English
format Article
sources DOAJ
author Olga Barbarash
Olga Gruzdeva
Evgenya Uchasova
Ekaterina Belik
Yulia Dyleva
Victoria Karetnikova
spellingShingle Olga Barbarash
Olga Gruzdeva
Evgenya Uchasova
Ekaterina Belik
Yulia Dyleva
Victoria Karetnikova
Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study
Archives of Medical Science
type 2 diabetes mellitus
adipokines
ghrelin
tumor necrosis factor 
myocardial infarction
author_facet Olga Barbarash
Olga Gruzdeva
Evgenya Uchasova
Ekaterina Belik
Yulia Dyleva
Victoria Karetnikova
author_sort Olga Barbarash
title Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study
title_short Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study
title_full Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study
title_fullStr Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study
title_full_unstemmed Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study
title_sort biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study
publisher Termedia Publishing House
series Archives of Medical Science
issn 1734-1922
1896-9151
publishDate 2017-01-01
description Introduction : On average, 19–23% of patients with acute myocardial infarction (MI) suffer from type 2 diabetes mellitus, which is newly diagnosed in a significant number of patients. Both classic carbohydrate metabolism and lipid metabolism may be promising diagnostic markers for insulin resistance in acute coronary syndrome. Material and methods : Two hundred patients (130 males and 70 females aged 61.4 ±1.12 years) with ST-segment elevation MI were included in the study. Patients were divided into two groups based on manifestations of diabetes: (1) 171 patients without diabetes within 1 year after MI; and (2) 29 patients with manifestations of diabetes. The control group comprised 33 people without diseases of the cardiovascular system and diabetes and was matched by age and gender with patients. Results : In patients with an imbalanced adipokine state during the acute phase of MI, we noted an increased concentration of free fatty acids (p > 0.05) and reduced ghrelin levels and activation of the proinflammatory and thrombotic potentials of blood plasma. Patients who developed diabetes 1 year after MI showed hospital stays with more pronounced changes in the study parameters. Conclusions : The most informative biochemical parameters associated with the development of diabetes at 1 year after MI were adiponectin, retinol protein, ghrelin, tumor necrosis factor , and plasminogen activator inhibitor.
topic type 2 diabetes mellitus
adipokines
ghrelin
tumor necrosis factor 
myocardial infarction
url https://www.termedia.pl/Biochemical-markers-of-type-2-diabetes-as-a-late-complication-of-myocardial-infarction-a-case-control-study,19,29146,1,1.html
work_keys_str_mv AT olgabarbarash biochemicalmarkersoftype2diabetesasalatecomplicationofmyocardialinfarctionacasecontrolstudy
AT olgagruzdeva biochemicalmarkersoftype2diabetesasalatecomplicationofmyocardialinfarctionacasecontrolstudy
AT evgenyauchasova biochemicalmarkersoftype2diabetesasalatecomplicationofmyocardialinfarctionacasecontrolstudy
AT ekaterinabelik biochemicalmarkersoftype2diabetesasalatecomplicationofmyocardialinfarctionacasecontrolstudy
AT yuliadyleva biochemicalmarkersoftype2diabetesasalatecomplicationofmyocardialinfarctionacasecontrolstudy
AT victoriakaretnikova biochemicalmarkersoftype2diabetesasalatecomplicationofmyocardialinfarctionacasecontrolstudy
_version_ 1725317659128496128